Recombinant Human EBNA1 Protein，His

EBNA1 (Epstein-Barr Nuclear Antigen 1) is a critical protein expressed by the Epstein-Barr virus (EBV), which is associated with various human diseases, including infectious mononucleosis and several types of cancer, such as Burkitt lymphoma and nasopharyngeal carcinoma. EBNA1 plays a vital role in the viral life cycle by maintaining the viral genome in latently infected cells and regulating the transcription of other viral genes. Given its pivotal function in disease pathology, EBNA1 has emerged as a target for therapeutic interventions and vaccine development. Research into recombinant EBNA1 proteins has focused on elucidating their structural and functional properties, understanding their interactions with host cell mechanisms, and investigating their potential as biomarkers for EBV-associated diseases. The study of EBNA1 also provides insights into the virus's evasion of the host immune response, which is crucial for developing effective treatments. Current advancements in recombinant protein expression technologies have facilitated the production of high-purity EBNA1, allowing researchers to perform detailed biochemical assays and structural analyses. These efforts aim to leverage EBNA1's unique characteristics for the development of novel diagnostic tools and therapeutic strategies against EBV-related conditions. As the prevalence of EBV is widespread, understanding EBNA1's molecular mechanisms is paramount, not only for advancing virology but also for improving public health outcomes related to EBV infections.